首页> 外国专利> Production of recombinant adenovirus, useful e.g. in gene therapy and genomics, by homologous recombination between parent and shuttle plasmids

Production of recombinant adenovirus, useful e.g. in gene therapy and genomics, by homologous recombination between parent and shuttle plasmids

机译:重组腺病毒的生产,例如通过亲本和穿梭质粒之间的同源重组进行基因治疗和基因组学研究

摘要

Production of adenovirus (AdV) by homologous recombination between shuttle plasmid (P1) and parent plasmid (P2) to produce a final plasmid (P3) containing a complete, recombinant AdV genome. This genome is excised as a linear sequence and inserted into a prokaryotic packaging cells to produce AdV containing a complete genome. Production of adenovirus (AdV) by homologous recombination between shuttle plasmid (P1) and parent plasmid (P2) to produce a final plasmid (P3) containing a complete, recombinant AdV genome. This genome is excised as a linear sequence and inserted into a prokaryotic packaging cells to produce AdV containing a complete genome. P1, preferably prokaryotic, contains a truncated AdV genome and at least one heterologous nucleic acid (I) and P2 contains a truncated AdV genome, complementary to that in P1. Independent claims are also included for the following: (a) P1 that contains an AdV ITR (inverted terminal repeat), (I) (or a site for its introduction) and an AdV homology sequence, with ITR flanked by a restriction site not present in the AdV genome; (b) nucleic acid library cloned in P1; (c) P2; (d) cells containing one or more of P1 and P2; (e) a method for preparing AdV libraries; (f) AdV libraries produced by method (e) comprising AdV containing nucleic acid inserts from: (i) library of cDNA, genomic DNA or synthetic DNA; (ii) a library of (semi-)random oligonucleotides; or (iii) a library of sequences able to bind to DNA; and (g) kits containing P1 and P2.
机译:通过穿梭质粒(P1)和亲本质粒(P2)之间的同源重组产生腺病毒(AdV),以产生包含完整重组AdV基因组的最终质粒(P3)。将该基因组作为线性序列切除,并插入原核包装细胞中以产生含有完整基因组的AdV。通过穿梭质粒(P1)和亲本质粒(P2)之间的同源重组产生腺病毒(AdV),以产生包含完整重组AdV基因组的最终质粒(P3)。将该基因组作为线性序列切除,并插入原核包装细胞中以产生含有完整基因组的AdV。 P1,优选为原核的,包含截短的AdV基因组和至少一个异源核酸(I),P2包含截短的AdV基因组,与P1中的互补。还包括以下方面的独立权利要求:(a)包含AdV ITR(反向末端重复序列),(I)(或其引入位点)和AdV同源序列的P1,ITR旁没有限制性位点在AdV基因组中; (b)克隆在P1中的核酸文库; (c)P2; (d)包含一个或多个P1和P2的单元; (e)制备AdV库的方法; (f)通过方法(e)产生的AdV文库,其包含含有来自以下方面的核酸插入物的AdV:(i)cDNA,基因组DNA或合成DNA的文库; (ii)(半)随机寡核苷酸的文库;或(iii)能够结合DNA的序列文库;或(g)包含P1和P2的套件。

著录项

  • 公开/公告号FR2799472A1

    专利类型

  • 公开/公告日2001-04-13

    原文格式PDF

  • 申请/专利权人 AVENTIS PHARMA S.A.;

    申请/专利号FR19990012521

  • 发明设计人 JEAN JACQUES ROBERT;

    申请日1999-10-07

  • 分类号C12N7/01;C12N15/64;C12N15/66;C12N15/861;

  • 国家 FR

  • 入库时间 2022-08-22 01:07:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号